Vimentin Antikörper (Ser56)
Kurzübersicht für Vimentin Antikörper (Ser56) (ABIN5957497)
Target
Alle Vimentin (VIM) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Ser56
-
Spezifität
- CTRCT30,Epididymis luminal protein 113,FLJ36605,HEL113,VIM,VIME,Vimentin
-
Aufreinigung
- Affinity purification
-
Immunogen
- Synthesized peptide derived from human Vimentin around the non-phosphorylation site of Ser56.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000, IHC 1:100-1:300, IF 1:200-1:1000, ELISA 1:20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
-
: "Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts." in: World journal of gastroenterology, Vol. 23, Issue 48, pp. 8512-8525, (2018) (PubMed).
-
: "Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts." in: World journal of gastroenterology, Vol. 23, Issue 48, pp. 8512-8525, (2018) (PubMed).
-
- Vimentin (VIM)
-
Andere Bezeichnung
- Vimentin
-
Hintergrund
- Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally.Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2.
-
Molekulargewicht
- 54kDa
-
Gen-ID
- 7431
-
UniProt
- P08670
-
Pathways
- Caspase Kaskade in der Apoptose
Target
-